RayzeBio, Inc. Common Stock

NASDAQ
RYZB
Stock
Yield per half year: 0%
Dividend yield: 0%
Sector: Healthcare

Reporting RayzeBio, Inc. Common Stock

Capitalization

2020 2021 2022 2023 LTM Average for 5 years CAGR 5
Net profit, bln $
-0.0069 -0.0294 -0.0686 -0.0635 -0.0635 -0.0421 74.17
EV, bln $
-0.143 -0.0415 -0.1186 -0.1010 -6.05
EBIT, bln $
-0.0069 -0.0394 -0.0721 -0.0395 118.62
EBITDA, bln $
-0.0067 -0.0389 -0.0706 -0.0387 119.24
OIBDA $
-0.0067 -0.0489 -0.0741 -0.0432 122.80
Book value, bln $
-0.0028 -0.0546 -0.1113 -0.0562 241.28
FCF, bln $
-0.0028 -0.0367 -0.0608 -0.0907 -0.0907 -0.0478 138.57
Operating Cash Flow, bln $
-0.0023 -0.0311 -0.0517 -0.056 -0.056 -0.0353 122.13
Operating profit, bln $
-0.0069 -0.0394 -0.0721 -0.0757 -0.0757 -0.0485 82.00
Operating expenses, bln $
0.0069 0.0394 0.0721 0.0757 0.0757 0.0485 82.00
CAPEX, bln $
0.000461 0.0056 0.0091 0.0346 0.0346 0.0124 194.34


Balance sheet

2020 2021 2022 2023 LTM Average for 5 years CAGR 5
Cash, bln $
0.1437 0.0506 0.1292 0.1078 -3.48
Short-Term Investments $
0.0031 0.1486 0.1671 0.1063 277.75
Accounts Receivable $
0.0000 0.0005 0.0005 0.0005 0.00
Total Current Assets $
0.1471 0.2024 0.3 0.2165 26.81
Net assets, bln $
0.0012 0.0136 0.0244 0.0131 172.94
Assets, bln $
0.1484 0.2164 0.3248 0.2299 29.84
Short-Term Debt $
0.000763 0.0018 0.0011 0.0012 12.97
Liabilities, bln $
0.1513 0.271 0.4361 0.2861 42.31
Net debt, bln $
-0.143 -0.0415 -0.1186 -0.1010 -6.05
Debt, bln $
0.000763 0.0091 0.0106 0.0068 140.40
Interest Income $
0 0.000265 0.0035 0.0122 0.0053 258.40
Net interest income, bln $
0 0.000265 0.0035 0.0122 0.0122 0.0053 258.40
Amortization, bln $
0.000213 0.000455 0.0015 0.0007 91.68


Share

2020 2021 2022 2023 2024 2025 LTM Average for 5 years CAGR 5
EPS -0.1716 -0.7304 -1.75 -3.82 -1.6180 117.21
Share price 62.17 62.49 62.49 62.49 62.38 0.17
Number of shares, mln 40.31 40.31 39.22 39.95 -0.91
FCF/share -0.0693 -0.911 -1.55 -0.8434 181.75


Efficiency

2020 2021 2022 2023 2024 2025 LTM Industry average Average for 5 years CAGR 5
ROE, % 244.12 102.58 82.72 17.60 143.14 -30.28
ROA, % -4.66 -16.14 -25.35 5.71 -15.3833 75.87
ROS, % 0 0 0 0 13.36
ROCE, % -4.71 -18.73 -22.94 0 0 29.73 -15.4600 69.51
EBIT margin 0 0 18.53
EBITDA margin 0 0 26.10
Operational efficiency, % 0 0 0 0 16.64


Coefficients

2020 2021 2022 2023 2024 2025 LTM Industry average Average for 5 years CAGR 5
P/FCF
0 0 0 0 8.97
E/P
0 0 0 0 0.03
EV/EBIT
20.66 1.05 1.64 0 0 0 88.11 7.78 -57.02
EV/EBITDA
21.31 1.07 1.68 53.63 8.02 -57.12
EV/S
0 0 0 0 8.36
EV/FCF
51.19 1.13 1.95 0 0 0 21.77 18.09 -66.35
Debt/EBITDA
-0.1137 -0.2327 -0.1497 0 0 0 0 2.61 -0.1654 9.60
Netdebt/Ebitda
21.31 1.07 1.68 0 0 0 0 0.49 8.02 -57.12
Debt/Ratio
0.0051 0.0419 0.0325 0 0 0 0 0.24 0.0265 85.40
Debt/Equity
-0.2693 -0.166 -0.095 0 0 0 0 2.82 -0.1768 -29.34
Debt/Net Income
-0.1103 -0.3076 -0.1541 0 0 0 0 10.75 -0.1907 11.79
PEG
0 0 -67.37
Beta
15.65 0 0 0 -0.03 15.65 0.00
Altman Index
0 0 0 0 12.59


Dividends

LTM Industry average Average for 5 years CAGR 5
Dividend
0
Dividend yield, %
0 1.71


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription